Index of reports
> Cases with Decreased Appetite (7)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Roferon-A (Interferon Alfa-2A) where reactions include decreased appetite. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Roferon-A side effects in female
Reported by a consumer/non-health professional from Brazil on 2012-08-16
Patient: female, weighing 59.0 kg (129.8 pounds)
Reactions: Weight Decreased, Hepatitis C, Nausea, Chills, Hypotension, Pyrexia, Depression, Decreased Appetite
Drug(s) suspected as cause:
Roferon-A
Other drugs received by patient: Miosan; Ribavirin
Possible Roferon-A side effects in
Reported by a physician from United States on 2012-08-06
Patient:
Reactions: Weight Decreased, Blood Creatine Phosphokinase Increased, Pyrexia, Cardiac Disorder, Cerebral Haemorrhage, Dyspepsia, DRY Mouth, Blood Creatinine Increased, Blood Alkaline Phosphatase Increased, Stomatitis, Intracranial Tumour Haemorrhage, Anaemia, Aspartate Aminotransferase Increased, Neutropenia, Amylase Increased, Myalgia, Fatigue, Blood Uric Acid Increased, Myocardial Infarction, Thrombocytopenia, Decreased Appetite, Dyspnoea, Vomiting, Nausea, Lymphopenia, Alanine Aminotransferase Increased, Palmar-Plantar Erythrodysaesthesia Syndrome, Rash, Mucosal Inflammation, Hypophosphataemia, Diarrhoea, Respiratory Failure, Arthralgia, Neoplasm Malignant, Ejection Fraction Decreased, Hypothyroidism, Lipase Increased, Hypertension, Asthenia, Leukopenia, Influenza Like Illness
Adverse event resulted in: death
Drug(s) suspected as cause:
Roferon-A
Dosage: given on nonconsecutive days, 3 mu at three times a week during the first week.
Indication: Metastatic Renal Cell Carcinoma
Roferon-A
Dosage: given 6 mu three times a week during second week.
Roferon-A
Dosage: given 9 mu three times a week thereafter.
Possible Roferon-A side effects in male
Reported by a physician from Hungary on 2012-07-09
Patient: male, weighing 57.0 kg (125.4 pounds)
Reactions: Haemoglobin Decreased, Cardiopulmonary Failure, Asthenia, Decreased Appetite
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Roferon-A
Dosage: reported as roferon.dose: 3 mu. frequency weekly 3
Indication: Renal Cell Carcinoma
Start date: 2008-09-25
End date: 2008-10-08
Avastin
Dosage: frequency reported as bi weekly
Indication: Renal Cell Carcinoma
Start date: 2008-09-25
End date: 2008-10-08
Other drugs received by patient: Ensure
Possible Roferon-A side effects in male
Reported by a individual with unspecified qualification from France on 2012-06-20
Patient: male, weighing 75.0 kg (165.0 pounds)
Reactions: Confusional State, Hypoglycaemia, Amnesia, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Roferon-A
Indication: Metastatic Renal Cell Carcinoma
Start date: 2009-03-31
End date: 2010-01-21
Avastin
Indication: Metastatic Renal Cell Carcinoma
Start date: 2009-03-31
End date: 2010-01-18
Other drugs received by patient: Omix; Ginkogink; Imodium; Acetaminophen; Aspirin; Omeprazole; Vitamin D; Lexomil; Glucophage; Dipyridamole; Ezetimibe; Motilium-M
Possible Roferon-A side effects in female
Reported by a physician from Korea, Republic of on 2012-06-18
Patient: female, weighing 50.3 kg (110.7 pounds)
Reactions: Myalgia, Fatigue, Ventricular Tachycardia, Cardiac Arrest, Decreased Appetite
Adverse event resulted in: death
Drug(s) suspected as cause:
Avastin
Indication: Renal Cell Carcinoma
Start date: 2010-02-23
End date: 2010-11-05
Roferon-A
Indication: Renal Cell Carcinoma
Start date: 2010-02-23
End date: 2010-11-05
Possible Roferon-A side effects in male
Reported by a physician from Germany on 2012-06-14
Patient: male, weighing 82.0 kg (180.4 pounds)
Reactions: Weight Decreased, Drug Ineffective, Neoplasm Malignant, Anaemia, General Physical Health Deterioration, Anaemia of Malignant Disease, Decreased Appetite
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Avastin
Start date: 2010-10-11
Roferon-A
Start date: 2010-09-27
Avastin
Start date: 2011-01-30
Roferon-A
Start date: 2010-10-11
Avastin
Indication: Metastatic Renal Cell Carcinoma
Start date: 2010-08-02
End date: 2010-09-27
Roferon-A
Indication: Metastatic Renal Cell Carcinoma
Start date: 2010-08-02
End date: 2010-09-27
Possible Roferon-A side effects in male
Reported by a physician from Germany on 2012-06-12
Patient: male, weighing 70.0 kg (154.0 pounds)
Reactions: Diarrhoea, Nausea, General Physical Health Deterioration, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Avastin
Start date: 2010-08-09
Avastin
Dosage: last dose 0n 04/feb/2011
End date: 2011-02-04
Roferon-A
Dosage: 3x6 mio ie
Start date: 2010-08-02
Roferon-A
Dosage: 9 mio/ie
Start date: 2010-08-11
Roferon-A
Dosage: most recent dose on 28-jul-2010, 3x9mio ie
Indication: Metastatic Renal Cell Carcinoma
Start date: 2010-06-23
End date: 2010-07-28
Avastin
Start date: 2010-08-02
Roferon-A
Dosage: last dose on 04/feb/2011
End date: 2011-02-04
Avastin
Dosage: most recent dose on 07/jul/2010
Indication: Metastatic Renal Cell Carcinoma
Start date: 2010-06-23
End date: 2010-07-26
|